SGLT-i Modify Exosomal Protein Composition: A potential Mechanism for Cardioprotective Effects. Poster

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F25%3A00086024" target="_blank" >RIV/00023001:_____/25:00086024 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

SGLT-i Modify Exosomal Protein Composition: A potential Mechanism for Cardioprotective Effects. Poster

Original language description

Sodium-glucose cotransporter inhibitors 2 (SGLT-2i) are widely used in diabetestreatment. Beyond their glucose-lowering effects, they provide broader benefits, includingsignificant cardioprotective effects. SGLT-i help manage heart failure and reducecardiovascular complications. However, the precise mechanisms underlying these additionaleffects remain unclear.

Czech name

—

Czech description

—

Type

O - Miscellaneous

CEP classification

—

OECD FORD branch

30202 - Endocrinology and metabolism (including diabetes, hormones)

Project

<a href="/en/project/LX22NPO5104" target="_blank" >LX22NPO5104: National Institute for Research of Metabolic and Cardiovascular Diseases</a><br>

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year

2025

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů